AI assistant
Sending…
RESMED INC — Director's Dealing 2014
May 16, 2014
30071_dirs_2014-05-16_40ae1b77-e064-4a9b-81ad-bde83f518aae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-05-14
Reporting Person: ROBERTS CHRISTOPHER G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-14 | ResMed Common Stock | M | 36000 | $21.025 | Acquired | 120988 | Direct |
| 2014-05-14 | ResMed Common Stock | M | 40500 | $16.498 | Acquired | 161488 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-14 | ResMed Common Stock Options | $21.025 | M | 36000 | Acquired | 2014-11-07 | ResMed Common Stock (36000) | Direct |
| 2014-05-14 | ResMed Common Stock Options | $16.498 | M | 40500 | Acquired | 2015-07-01 | ResMed Common Stock (40500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 234900 | Indirect |
| ResMed Common Stock | 136000 | Indirect |
| ResMed Common Stock | 23200 | Indirect |
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29